Harshal Kirane1, Elina Drits1, Seungjun Ahn2, Sandeep Kapoor3, Jonathan Morgenstern4, Joseph Conigliaro5, Jay Enden6. 1. Department of Psychiatry and Behavioral Sciences, Northwell Health-Staten Island University Hospital, Staten Island, New York; Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York. 2. Biostatistics Unit, Feinstein Institute for Medical Research, Manhasset, New York. 3. Division of Internal Medicine, Northwell Health-North Shore University Hospital, Manhasset, New York; Northwell Health-Department of Psychiatry and Behavioral Sciences, New Hyde Park, New York; Northwell Health-Department of Emergency Medicine, New Hyde Park, New York; Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York. 4. Northwell Health-Department of Psychiatry and Behavioral Sciences, New Hyde Park, New York; Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York. 5. Division of Internal Medicine, Northwell Health-North Shore University Hospital, Manhasset, New York; Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York. 6. Division of Internal Medicine, Northwell Health-Southside Hospital, Bay Shore, NY; Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
Abstract
OBJECTIVE: To assess provider practices and attitudes toward addiction care and pain management within a large healthcare system, as well as to determine the impact of prior training and perceived effectiveness of organizational implementation strategies. DESIGN: A cross-sectional study. SETTING: Large healthcare organization comprising 21 hospitals. PARTICIPANTS: Three hundred and thirteen healthcare providers within a large healthcare organization. MAIN OUTCOME MEASURES: Training, practices, and attitudes toward opioid-related care. METHODS: One thousand providers including physicians (MD/DO) and physician extenders (NP/PA) were contacted via email request. The Mann-Whitney test or Fisher's exact test, as appropriate, was used for comparisons of continuous and categorical variables, respectively. RESULTS: Providers lacked prior pain management (36 percent), addiction (38 percent), or buprenorphine training (92 percent). Few providers were confident in treating opioid use disorders (OUD) (19 percent) and opioid tapering (24 percent) but interested in safe prescribing practices (81 percent). While most providers preferred to refer patients for OUD (89 percent), only a small portion felt appropriate services were readily available (22 percent). Trained providers appear significantly more engaged in checking Prescription Drug Monitoring Program database [median = 1 (Q1 = 1, Q3 = 2) vs 2(1, 3); p < 0.001], comfortable obtaining urine drug screens [2(2, 3) vs 3(2, 4); p < 0.002], and willing to treat OUD with additional support [3(2, 4) vs 4(3, 4); p < 0.022] compared to non-trained providers. Primary care providers were more likely to view OUDs in their scope of practice [4(2, 5) vs 4(3, 5); p < 0.016] and willing to treat OUD with additional support [3(2, 3) vs 3(2, 4); p < 0.0007] compared to specialists. Buprenorphine providers appear to have more confidence in skills for OUD [2(1, 3) vs 4(3, 4); p < 0.0001] and tapering [2(1, 2) vs 4(3, 5); p < 0.0001], and diminished preference to refer [2(1, 5) vs 1(1, 2); p < 0.0009] compared to non-buprenorphine providers. CONCLUSIONS: Providers within a large healthcare system lack training and confidence in management of opioid-related care. Buprenorphine training positively modified key attitudes toward addiction care, yet engagement in medication-assisted treatment remains limited. Providers are concerned about opioid risks, and view guideline implementation and direct input from addiction specialists as effective organizational strategies. Further research is needed to clarify the efficacy of such approaches.
OBJECTIVE: To assess provider practices and attitudes toward addiction care and pain management within a large healthcare system, as well as to determine the impact of prior training and perceived effectiveness of organizational implementation strategies. DESIGN: A cross-sectional study. SETTING: Large healthcare organization comprising 21 hospitals. PARTICIPANTS: Three hundred and thirteen healthcare providers within a large healthcare organization. MAIN OUTCOME MEASURES: Training, practices, and attitudes toward opioid-related care. METHODS: One thousand providers including physicians (MD/DO) and physician extenders (NP/PA) were contacted via email request. The Mann-Whitney test or Fisher's exact test, as appropriate, was used for comparisons of continuous and categorical variables, respectively. RESULTS: Providers lacked prior pain management (36 percent), addiction (38 percent), or buprenorphine training (92 percent). Few providers were confident in treating opioid use disorders (OUD) (19 percent) and opioid tapering (24 percent) but interested in safe prescribing practices (81 percent). While most providers preferred to refer patients for OUD (89 percent), only a small portion felt appropriate services were readily available (22 percent). Trained providers appear significantly more engaged in checking Prescription Drug Monitoring Program database [median = 1 (Q1 = 1, Q3 = 2) vs 2(1, 3); p < 0.001], comfortable obtaining urine drug screens [2(2, 3) vs 3(2, 4); p < 0.002], and willing to treat OUD with additional support [3(2, 4) vs 4(3, 4); p < 0.022] compared to non-trained providers. Primary care providers were more likely to view OUDs in their scope of practice [4(2, 5) vs 4(3, 5); p < 0.016] and willing to treat OUD with additional support [3(2, 3) vs 3(2, 4); p < 0.0007] compared to specialists. Buprenorphine providers appear to have more confidence in skills for OUD [2(1, 3) vs 4(3, 4); p < 0.0001] and tapering [2(1, 2) vs 4(3, 5); p < 0.0001], and diminished preference to refer [2(1, 5) vs 1(1, 2); p < 0.0009] compared to non-buprenorphine providers. CONCLUSIONS: Providers within a large healthcare system lack training and confidence in management of opioid-related care. Buprenorphine training positively modified key attitudes toward addiction care, yet engagement in medication-assisted treatment remains limited. Providers are concerned about opioid risks, and view guideline implementation and direct input from addiction specialists as effective organizational strategies. Further research is needed to clarify the efficacy of such approaches.
Authors: Katherine Mackey; Stephanie Veazie; Johanna Anderson; Donald Bourne; Kim Peterson Journal: J Gen Intern Med Date: 2020-11-03 Impact factor: 5.128
Authors: Donna M Windish; Jillian S Catalanotti; Aimee Zaas; Michael Kisielewski; John P Moriarty Journal: J Gen Intern Med Date: 2021-11-02 Impact factor: 6.473
Authors: Kristen Curcija; Linda Zittleman; Mary Fisher; Donald E Nease; L Miriam Dickinson; Dionisia de la Cerda; Christin Sutter; Jen Ancona; James Rank; John M Westfall Journal: J Rural Health Date: 2020-11-26 Impact factor: 5.667